Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Benzoic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100395227C reveals a safer ethanol-water solvent system for p-nitrobenzoic acid production, offering higher yields and reduced toxicity for global supply chains.
Novel copper-catalyzed route reduces costs and improves purity for insomnia drug intermediates, ensuring supply chain stability and commercial scalability.
Patent CN101735167B reveals a green synthesis route for 6-nitrosaccharin, offering cost reduction in agrochemical intermediate manufacturing and superior supply chain reliability.
Patent CN102211995A reveals an efficient ethanol-based synthesis for 2,6-dihydroxybenzoic acid, offering reduced energy consumption and superior yield for agrochemical manufacturing.
Patent CN103193654A reveals a high-yield metalloporphyrin catalytic oxidation process for o-nitrobenzoic acid, offering significant cost reduction and supply chain efficiency for pharmaceutical intermediates.
Patent CN118652170A enables high-yield synthesis of Dapagliflozin intermediates with reduced waste and cost for global supply chains.
Patent CN112409196A reveals a high-yield Delbin reaction route for aminomethylbenzoic acid, offering significant cost reduction and superior purity for pharmaceutical supply chains.
Patent CN108218699A reveals ionic liquid catalysis for UV-2908. Offers high purity and cost reduction in plastic additives manufacturing for reliable supply chain partners.
Patent CN112979448A reveals a green synthesis route for SGLT-2 inhibitor intermediates with >99% purity and recyclable reagents.
Novel synthesis route offers high yield and safety for finafloxacin intermediate production. Reduces toxic waste and ensures supply chain stability for global pharmaceutical manufacturers seeking reliable partners.
Patent CN111004089B reveals efficient one-step decarboxylation. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN113582847B reveals high-purity iodobenzoic acid synthesis. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical intermediates.
Patent CN120329198A details a scalable salicylic acid route for 2-fluoro-3-nitrobenzoic acid, offering superior purity and cost efficiency for global supply chains.
Novel catalytic route for high-purity fluoroquinolone intermediates. Reduces alkali usage and boosts yield to 82.5% via one-pot synthesis.
Patent CN111253271B reveals a continuous flow method for methyl 2-amino-3-nitrobenzoate, enhancing safety and yield for ARB drug intermediates.
Novel patent CN112624981B details a high-yield route for Olaparib intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced synthesis of difluorodichlorobenzimide via halogen exchange. High-purity reference standards for levofloxacin intermediates. Cost-effective manufacturing solutions.
Advanced Pd-catalyzed synthesis of ortho-deuterated benzoic acid derivatives. High selectivity, recyclable directing groups, and scalable manufacturing for pharmaceutical intermediates.
Patent CN113929588B reveals safer bromination for pharmaceutical intermediates. Reduces equipment corrosion and enables sustainable recycling for supply chain stability.
Patent CN114920661A details a cost-effective synthesis of 2-fluoro-3-aminobenzoic acid, a key broflanilide intermediate, offering high purity and scalable manufacturing.